CHMP backs Celltrion’s regdanvimab antibody for COVID-19The EU looks set to approve emergency use of a third antibody therapy for COVID-19 after its human Share XCHMP backs Celltrion’s regdanvimab antibody for COVID-19https://pharmaphorum.com/news/chmp-backs-celltrions-regdanvimab-antibody-for-covid-19/
The Brexit deal; shot in the arm or kick in the teeth for the pharma sector?The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as Share XThe Brexit deal; shot in the arm or kick in the teeth for the pharma sector?https://pharmaphorum.com/market-access-2/the-brexit-deal-for-the-pharma-sector/
Boris Johnson slammed for saying ‘greed’ is behind UK vaccine successBoris Johnson’s sense of humour seems to have got him into trouble again, at the most delicate of Share XBoris Johnson slammed for saying ‘greed’ is behind UK vaccine successhttps://pharmaphorum.com/news/boris-johnson-slammed-for-saying-greed-is-behind-uk-vaccine-success/
J&J’s COVID-19 shot backed for emergency use in EUThe EU’s medicines regulator has recommended granting conditional approval to a fourth COVID-19 vaccine – a single-dose shot Share XJ&J’s COVID-19 shot backed for emergency use in EUhttps://pharmaphorum.com/news/jjs-covid-19-shot-backed-for-emergency-use-in-eu/
EMA starts rolling review of Sputnik V COVID vaccineWith EU countries breaking ranks in order to get access to the Russian Sputnik V COVID-19 vaccine, the Share XEMA starts rolling review of Sputnik V COVID vaccinehttps://pharmaphorum.com/news/ema-starts-rolling-review-of-sputnik-v-covid-vaccine/
Why cell therapy manufacture is a team sportLouis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that Share XWhy cell therapy manufacture is a team sporthttps://pharmaphorum.com/market-access-2/why-cell-therapy-manufacture-is-a-team-sport/
UK parliament backs EU trade deal, as industry sifts through detailThe post-Brexit trade deal agreed on Christmas Eve has been overwhelmingly backed by the UK parliament, providing some Share XUK parliament backs EU trade deal, as industry sifts through detailhttps://pharmaphorum.com/news/uk-parliament-backs-eu-trade-deal-as-industry-sifts-through-detail/
Roche claims EU okay for Herceptin/Perjeta combination PhesgoRoche has secured EU approval for Phesgo, a fixed-dose combination of its breast cancer drugs Herceptin and Perjeta Share XRoche claims EU okay for Herceptin/Perjeta combination Phesgohttps://pharmaphorum.com/news/roches-claims-eu-okay-for-herceptin-perjeta-combination-phesgo/
UK, EU agree Northern Ireland medicines, food border controlsThe UK and EU have reached an agreement on border checks for Northern Ireland that should guarantee that Share XUK, EU agree Northern Ireland medicines, food border controlshttps://pharmaphorum.com/news/uk-eu-agree-northern-ireland-medicines-food-border-controls/
